Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9ES82

Entry ID Method Resolution Chain Position Source
AF-Q9ES82-F1 Predicted AlphaFoldDB

20 variants for Q9ES82

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389432516 27 G>E No EVA
rs3389331950 41 F>Y No EVA
rs3389410694 65 V>E No EVA
rs3389417026 75 L>I No EVA
rs3389432480 85 T>S No EVA
rs3406921048 121 V>G No EVA
rs3412921044 169 Q>H No EVA
rs215856394 193 P>A No EVA
rs3406276375 198 T>S No EVA
rs3389423699 203 L>P No EVA
rs3389413931 214 W>R No EVA
rs3389433136 224 N>Y No EVA
rs3389425846 251 K>R No EVA
rs3389414357 259 R>H No EVA
rs3389418280 267 L>I No EVA
rs3389425820 285 D>V No EVA
rs3389396802 295 S>F No EVA
rs264373584 312 A>T No EVA
rs3389332006 322 P>S No EVA
rs243073944 338 N>T No EVA

No associated diseases with Q9ES82

No regional properties for Q9ES82

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9ES82

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
  • Cell membrane, sarcolemma
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
sarcolemma The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers.

1 GO annotations of molecular function

Name Definition
cAMP binding Binding to cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate).

6 GO annotations of biological process

Name Definition
heart development The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
regulation of heart rate Any process that modulates the frequency or rate of heart contraction.
regulation of membrane potential Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
sinoatrial node cell development The process whose specific outcome is the progression of a sinoatrial (SA) node cell over time, from its formation to the mature state. SA node cells are pacemaker cells that are found in the sinoatrial node.
skeletal muscle tissue development The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
striated muscle cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9HBU9 POPDC2 Popeye domain-containing protein 2 Homo sapiens (Human) PR
10 20 30 40 50 60
MSANGSSVAQ LLWQPPVCRS WKPDVEGAVY HLANCFLLMG FMAGSGVYGC FYLFGILGPG
70 80 90 100 110 120
YLCCVLWGWF DACGLDIVLW NVLLTVACLL QLAQLVYRVR VNTLPEEFNL LYRTLCLPLQ
130 140 150 160 170 180
VPLQVYKEIV HCCHEQVLTL ATEQTYAVEG ETPINRLSLL LSGRVRVSQD GQFLHYIFPY
190 200 210 220 230 240
QFMDSPEWES LHPSEEGTFQ VTLTAETECS YISWPRKNLY LLLNRERYIS RLFSALLGYD
250 260 270 280 290 300
ISEKLYTLND KLFAKFGLRF DIRLPSLYHV LSPSASDGEP ESEKDDEEAL EAAVSPAQAR
310 320 330 340 350 360
PICIVPTPPC SAPPATTNFP VPLPRARMPR MPRPDSGNLA SRRPLQNSSQ VMSRSQAPLA
PIHTPEL